Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares changing hands.
Bayer Aktiengesellschaft Price Performance
The stock has a market cap of $21.34 billion, a price-to-earnings ratio of -20.88 and a beta of 1.02. The stock has a fifty day simple moving average of $5.14 and a 200-day simple moving average of $6.64. The company has a current ratio of 1.32, a quick ratio of 0.81 and a debt-to-equity ratio of 1.19.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10). Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. The business had revenue of $10.96 billion during the quarter. As a group, equities research analysts expect that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
- Five stocks we like better than Bayer Aktiengesellschaft
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- The Risks of Owning Bonds
- Oilfield Leader SLB: An AI Name You Need to Know
- How to Start Investing in Real Estate
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.